References
- McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205–2219.
- Senel K, Kaya M, Energin F, et al. The investigation of our rheumatoid arthirtis patients’ for ocular involvement. MJAU 1995;27:104–106.
- Vignesh APP, Srinivasan R. Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies. Clin Ophthalmol 2015;9:393–397.
- Parida JR, Misra DP, Wakhlu A, et al. Is non-biological treatment of rheumatoid arthritis as good as biologics? World J Orthop 2015;6:278–283..
- Rossi D, Modena V, Sciascia S, et al. Rheumatoid arthritis: biological therapy other than anti-TNF. Int Immunopharmacol 2015;27:185–188.
- Salgado E, Maneiro JR. New therapies for rheumatoid arthritis. Med Clin (Barc) 2014;143:461–466.
- Agarwal SK. Biologic agents in rheumatoid arthritis: an update for managed care professionals. J Manag Care Pharm 2011;17:14–18.
- Klemencic S. Cotton wool spots as an indicator of methotrexate-induced blood dyscrasia. Optometry 2010;81:177–180.
- Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–324.
- Patel AM, Moreland LW. Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy. Drug Des Devel Ther 2010;4:263–278.
- Reddy SC, Gupta SD, Jain IS, et al. Ocular manifestations of rheumatoid arthritis. Indian J Ophthalmol 1977;25:20–26.
- Singh G, Salvador VB, Bagchi A, et al. Rheumatoid arthritis associated corneal ulceration with super imposed infection by methicillin resistant Staphylococcus aureus: a complicated type of corneal melt. Am J Case Rep 2014;15:523–525.
- Schargus M, Wolf F, Tony HP, et al. Correlation between tear film osmolarity, dry eye disease, and rheumatoid arthritis. Cornea 2014;33:1257–1261.
- Punjabi OS, Adyanthaya RS, Mhatre AD, et al. Rheumatoid arthritis is a risk factor for dry eye in the Indian population. Ophthalmic Epidemiol 2006;13:379–384.
- Villani E, Galimberti D, Viola F, et al. Corneal involvement in rheumatoid arthritis: an in vivo confocal study. Invest Ophthalmol Vis Sci 2008;49:560–564.
- Kim IG, Lee JH, Kim SS. Reduced corneal sensitivity in patients with rheumatoid arthritis. Cornea 2012;31:1381–1385.
- Kırboga K, Ucar M, Sarp U, et al. Ocular involvement in rheumatic diseases. Bozok Med J 2015;5:51–55.
- Markovitz E, Perry ZH, Tsumi E, et al. Ocular involvement and its’ manifestations in rheumatoid arthritis patients. Harefuah 2011;150:713–718.
- Petris CK, Almony A. Ophthalmic manifestations of rheumatologic disease: diagnosis and management. Mo Med 2012;109:53–58.
- Tong L, Thumboo J, Tan YK, et al. The eye: a window of opportunity in rheumatoid arthritis? Nat Rev Rheumatol 2014;10:552–560..
- Villani E, Galimberti D, Del Papa N, et al. Inflammation in dry eye associated with rheumatoid arthritis: cytokine and in vivo confocal microscopy study. Innate Immun 2013;19:420–427.
- Cingü AK, Cınar Y, Türkcü FM, et al. Evaluation of corneal parameters with scheimpflug imaging in patients with rheumatoid arthritis. Ocul Immunol Inflamm 2013;21:360–365.
- Prata TS, Sousa AK, Garcia Filho CA, et al. Assessment of corneal biomechanical properties and intraocular pressure in patients with rheumatoid arthritis. Can J Ophthalmol 2009;44:602
- Can ME, Erten S, Can GD, et al. Corneal biomechanical properties in rheumatoid arthritis. Eye Contact Lens 2015;41:382–385.
- Tas M, Oner V, Ozkaya E, Durmus M. Evaluation of corneal biomechanical properties in patients with rheumatoid arthritis: a study by ocular response analyzer. Ocul Immunol Inflamm 2014;22:224–227.
- Morarji J, Lightman S, Taylor SR. The eye in rheumatology. Br J Hosp Med (Lond) 2011;72:682–685.
- Freissler KA, Lang GE. The cornea and systemic diseases. Curr Opin Ophthalmol 1996;7:22–27.
- Thomas JW, Pflugfelder SC. Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab. Cornea 2005;24:742–744.
- Schuler S, Brunner M, Bernauer W. Rituximab and acute retinal necrosis in a patient with scleromalacia and rheumatoid arthritis. Ocul Immunol Inflamm 2015. [Epub ahead of print]. doi:10.3109/09273948.2014.999377.
- Matet A, Daruich A, Beydoun T, et al. Systemic adalimumab induces peripheral corneal infiltrates: a case report. BMC Ophthalmol 2015;15:57.